Bayer stock slips to EUR 49.42 as shares remain below the yearly high

Published on 09/23/2026 at 15:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bayer stock traded at EUR 49.42 on September 23, 2026, down 0.3 percent in Xetra trading. The shares remain 8.35 percent below the yearly high.

Flatlay auf weißem Untergrund: weiße runde Tabletten, Marmorstößel, grünes Pflanzenblatt, Glasflakon und gedrucktes DNA-Doppelhelix-Diagramm; Beschriftungskarte mit Text PHARMA — Top-down-Arrangement: weiße Tabletten, Mörser, grünes Blatt, DNA-Diagramm, Beschriftungskarte PHARMA, Illustration mit AI erstellt.

Bayer AG (ISIN DE000BAY0017) traded at EUR 49.42 on Xetra at 12:28 p.m. on September 23, 2026, down 0.3 percent from the previous close. The price remains below the 52-week high of EUR 53.92 reached on July 3, 2026, but stands above the 52-week low of EUR 25.78 recorded on November 7, 2025.

Stock remains below yearly high

The intraday range on September 23, 2026, extended from EUR 49.10 to EUR 49.42, while 278,528 shares had changed hands by 12:28 p.m. The stock was therefore 8.35 percent below its 52-week high, a quantified gap that puts the current quotation in the upper part of its annual range without marking a new high.

Earlier Xetra trading showed a similar pattern. At 9:28 a.m. on September 23, 2026, Bayer traded at EUR 49.36, down 0.4 percent, after opening at EUR 49.38, while the DAX stood at 25,630 points.

Recent approval supports valuation case

Recent coverage cited by Simply Wall St on September 22, 2026, linked the valuation discussion to the FDA approval of KERENDIA. The same report cited a 90-day share-price return of 24.93 percent and a one-year total shareholder return of 80.30 percent, both measured against a share price of EUR 49.46.

The valuation comparison is concrete: Simply Wall St cited analyst fair value of EUR 58.22 against a last close of EUR 49.46. That difference is EUR 8.76, or approximately 17.7 percent, although the cited fair-value figure is an analytical reference rather than a company forecast or a price target issued by Bayer.

Xetra close provides the reference

The latest completed Xetra close in the available dated market record was EUR 49.30 on September 22, 2026, up 0.55 percent. An afternoon quotation reached EUR 49.33 at 4:28 p.m. local time on the same date, providing the completed-session reference before the September 23 intraday quotation.

For investors, the key distinction is between the recent return figures and the current level: the 90-day return of 24.93 percent shows substantial appreciation from the earlier reference point, while the September 23 price still remained EUR 4.50 below the yearly high. The share-price gap and the KERENDIA approval therefore describe two different valuation signals.

Price stays below EUR 53.92

Bayer stock traded at EUR 49.42 on Xetra as of 12:28 p.m. on September 23, 2026. The current quotation was EUR 4.50 below the 52-week high of EUR 53.92 and EUR 23.64 above the 52-week low of EUR 25.78.